Bevacizumab plus irinotecan in recurrent glioblastoma

被引：34

作者：

Chamberlain, Marc C. ^{[1
]}

机构：

[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 06期

关键词：

D O I：

10.1200/JCO.2007.15.1605

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1012 / 1013

页数：2

共 10 条

[1] Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: Final report of NABTT 97-11 [J].

Batchelor, TT ;

Gilbert, MR ;

Supko, JG ;

Carson, KA ;

Nabors, LB ;

Grossman, SA ;

Lesser, GJ ;

Mikkelsen, T ;

Phuphanich, S .

NEURO-ONCOLOGY, 2004, 6 (01) :21-27

[2] Irinotecan in the treatment of glioma patients - Current and future studies of the North Central Cancer Treatment Group [J].

Buckner, JC ;

Reid, JM ;

Wright, K ;

Kaufmann, SH ;

Erlichman, C ;

Ames, M ;

Cha, S ;

O'Fallon, JR ;

Schaaf, LJ ;

Miller, LL .

CANCER, 2003, 97 (09) :2352-2358

[3] Salvage chemotherapy with CPT-11 for recurrent glioblastoma multiforme [J].

Chamberlain, MC .

JOURNAL OF NEURO-ONCOLOGY, 2002, 56 (02) :183-188

[4] Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography:: A pilot study [J].

Chen, Wei ;

Delaloye, Sibylle ;

Silverman, Daniel H. S. ;

Geist, Cheri ;

Czernin, Johannes ;

Sayre, James ;

Satyamurthy, Nagichettiar ;

Pope, Whitney ;

Lai, Albert ;

Phelps, Michael E. ;

Cloughesy, Timothy .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) :4714-4721

[5] Irinotecan therapy in adults with recurrent or progressive malignant glioma [J].

Friedman, HS ;

Petros, WP ;

Friedman, AH ;

Schaaf, LJ ;

Kerby, T ;

Lawyer, J ;

Parry, M ;

Houghton, PJ ;

Lovell, S ;

Rasheed, K ;

Cloughsey, T ;

Stewart, ES ;

Colvin, OM ;

Provenzale, JM ;

McLendon, RE ;

Bigner, DD ;

Cokgor, I ;

Haglund, M ;

Rich, J ;

Ashley, D ;

Malczyn, J ;

Elfring, GL ;

Miller, LL .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1516-1525

[6] MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy [J].

Pope, WB ;

Lai, A ;

Nghiemphu, P ;

Mischel, P ;

Cloughesy, TF .

NEUROLOGY, 2006, 66 (08) :1258-1260

[7] A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study [J].

Prados, MD ;

Lamborn, K ;

Yung, WKA ;

Jaeckle, K ;

Robins, HI ;

Mehta, M ;

Fine, HA ;

Wen, PY ;

Cloughesy, T ;

Chang, S ;

Nicholas, MK ;

Schiff, D ;

Greenberg, H ;

Junck, L ;

Fink, K ;

Hess, K ;

Kuhn, J .

NEURO-ONCOLOGY, 2006, 8 (02) :189-193

[8] Warm hands in cold age - On the need of a new world order of care [J].

Stark, A .

FEMINIST ECONOMICS, 2005, 11 (02) :7-36

[9] Bevacizumab plus irinotecan in recurrent glioblastoma multiforme [J].

Vredenburgh, James J. ;

Desjardins, Annick ;

Herndon, James E., II ;

Marcello, Jennifer ;

Reardon, David A. ;

Quinn, Jennifer A. ;

Rich, Jeremy N. ;

Sathornsumetee, Sith ;

Gururangan, Sridharan ;

Sampson, John ;

Wagner, Melissa ;

Bailey, Leighann ;

Bigner, Darell D. ;

Friedman, Allan H. ;

Friedman, Henry S. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) :4722-4729

[10] Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma [J].